Evidence map›Paper›PMID 27225932›Full record

ArticleThe EMBO journal2016

SIRT7 promotes genome integrity and modulates non-homologous end joining DNA repair.

Berta N Vazquez, Joshua K Thackray, Nicolas G Simonet, Noriko Kane-Goldsmith, Paloma Martinez-Redondo, Trang Nguyen, Samuel Bunting, Alejandro Vaquero, Jay A Tischfield, Lourdes Serrano

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 166 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
166citing papers in PubMed, 1 pooled it
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

166 citing papers in PubMed, 1 synthesis or guideline pooled it, 260 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. NADTrends in molecular medicine · 2025
    Review
  18. Article
  19. Review
  20. Review

106 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Berta N VazquezDepartment of Genetics, Human Genetics Institute of New Jersey, Rutgers University, Piscataway, NJ, USA.
Joshua K ThackrayDepartment of Genetics, Human Genetics Institute of New Jersey, Rutgers University, Piscataway, NJ, USA.
Nicolas G SimonetChromatin Biology Laboratory, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
Noriko Kane-GoldsmithDepartment of Genetics, Human Genetics Institute of New Jersey, Rutgers University, Piscataway, NJ, USA.
Paloma Martinez-RedondoChromatin Biology Laboratory, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
Trang NguyenDepartment of Genetics, Human Genetics Institute of New Jersey, Rutgers University, Piscataway, NJ, USA.
Samuel BuntingDepartment of Molecular Biology and Biochemistry, Rutgers University, Piscataway, NJ, USA.
Alejandro VaqueroChromatin Biology Laboratory, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
Jay A TischfieldDepartment of Genetics, Human Genetics Institute of New Jersey, Rutgers University, Piscataway, NJ, USA.
Lourdes SerranoDepartment of Genetics, Human Genetics Institute of New Jersey, Rutgers University, Piscataway, NJ, USA serrano@biology.rutgers.edu.ORCID 0000-0002-3409-9366
Rutgers, The State University of New Jersey · USInstitut d'Investigació Biomédica de Bellvitge · ES

Funding

TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Tracie Saunders · 1997 to 2026
$94.5M
Control of Commitment Steps in Mammalian Homologous RecombinationR01CA190858 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI BUNTING, SAMUEL · 2015 to 2021
$2.1M
NCI NIH HHS P30 CA072720NCI NIH HHS R01 CA190858
6 · The paper itself

Abstract

Sirtuins, a family of protein deacetylases, promote cellular homeostasis by mediating communication between cells and environment. The enzymatic activity of the mammalian sirtuin SIRT7 targets acetylated lysine in the N-terminal tail of histone H3 (H3K18Ac), thus modulating chromatin structure and transcriptional competency. SIRT7 deletion is associated with reduced lifespan in mice through unknown mechanisms. Here, we show that SirT7-knockout mice suffer from partial embryonic lethality and a progeroid-like phenotype. Consistently, SIRT7-deficient cells display increased replication stress and impaired DNA repair. SIRT7 is recruited in a PARP1-dependent manner to sites of DNA damage, where it modulates H3K18Ac levels. H3K18Ac in turn affects recruitment of the damage response factor 53BP1 to DNA double-strand breaks (DSBs), thereby influencing the efficiency of non-homologous end joining (NHEJ). These results reveal a direct role for SIRT7 in DSB repair and establish a functional link between SIRT7-mediated H3K18 deacetylation and the maintenance of genome integrity.

Indexed as

DNA DamageDNA End-Joining RepairAnimalsDNAMice, Inbred C57BLMice, KnockoutSirtuinsDNASirt7 protein, mouseSirtuinsDNA damagehistone acetylationnon‐homologous end joiningPARP1SIRT7

Identifiers

PMID27225932
PMCPMC4884211
OpenAlexW2406576771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.